BrightPath Biotherapeutics Co.,Ltd. 4594Short Interest
Estimated short interest in BrightPath Biotherapeutics Co.,Ltd. (4594) is 5.72% of shares outstanding as of 2026-11-18. Institutions holding 0.5% or more: Nomura International plc, Barclays Capital Securities Ltd, フィリップ証券株式会社 and 2 others.
Estimated short interest is the sum of positions of 0.5% or more reported within the past year. It excludes 2 institutions whose last report is more than a year old (1.98% in total). It also excludes 18 institutions that fell below 0.5%. How estimates are calculated
Disclosure History Summary
| First disclosure | 2017-08-30 |
|---|---|
| Latest disclosure | 2026-11-13 (Nomura International plc, 2.05%) |
| Reporting institutions | 26 firms (2204 reports) |
| Peak estimated short interest | 16.64% (2023-06-22, 11 holders) |
Short Interest Trend Last 5 years, by institution, % of shares outstanding
Estimated short interest stacked by institution, counting only positions of 0.5% or more reported within the past year. The 5 largest current holders are colored and the rest are grouped as "Others". Hover over (or tap) a bar to see the breakdown.
- Nomura International plc
- Barclays Capital Securities Ltd
- Arrowstreet Capital, Limited Partnership
- Mitsubishi UFJ Morgan Stanley Securities Co., Ltd.
- JPM Securities Japan Co Ltd.
- Others
Current Positions by Short Seller Latest report of each holder
| Last report | Short seller | Position (shares) | Ratio | Change | Status |
|---|---|---|---|---|---|
| 2026-11-13 | Nomura International plc | Position 2,893,300 shares | Ratio 2.05% | ▲0.07% | Holding |
| 2024-08-05 | Segregated Portfolio D | Position 1,117,000 shares | Ratio 1.39% | ▼0.06% | No report for 1+ year |
| 2026-11-09 | Barclays Capital Securities Ltd | Position 1,495,097 shares | Ratio 1.06% | ▼0.04% | Holding |
| 2025-12-29 | フィリップ証券株式会社 | Position 1,166,800 shares | Ratio 1.04% | ▲1.04% | Holding |
| 2026-11-03 | Arrowstreet Capital, Limited Partnership | Position 1,398,800 shares | Ratio 0.99% | ▼0.01% | Holding |
| 2023-08-28 | BNP Paribas Arbitrage SNC | Position 375,000 shares | Ratio 0.59% | ▼0.10% | No report for 1+ year |
| 2026-02-24 | Mitsubishi UFJ Morgan Stanley Securities Co., Ltd. | Position 775,000 shares | Ratio 0.58% | ▼0.11% | Holding |
| 2026-03-13 | Nomura Securities Co., Ltd. | Position 646,200 shares | Ratio 0.49% | ▼0.05% | Below 0.5% |
| 2021-04-22 | Deutsche Bank Aktiengesellschaft, London | Position 249,500 shares | Ratio 0.49% | ▼0.09% | Below 0.5% |
| 2026-03-13 | Morgan Stanley MUFG Securities Co., Ltd. | Position 656,200 shares | Ratio 0.49% | ▼0.05% | Below 0.5% |
| 2018-02-15 | OXAM QUANT FUND LIMITED | Position 206,100 shares | Ratio 0.49% | ▼0.02% | Below 0.5% |
| 2026-11-11 | GOLDMAN SACHS INTERNATIONAL | Position 701,800 shares | Ratio 0.49% | ▼0.03% | Below 0.5% |
| 2019-09-03 | Jin Investment Management Pte Ltd | Position 207,300 shares | Ratio 0.49% | ▼0.02% | Below 0.5% |
| 2026-07-16 | スパークス・アセット・マネジメント株式会社 | Position 674,000 shares | Ratio 0.48% | ▼0.06% | Below 0.5% |
| 2021-02-02 | Credit Suisse AG | Position 237,600 shares | Ratio 0.47% | ▼0.03% | Below 0.5% |
| 2024-07-02 | BNP Paribas Financial Markets SNC formerly known as BNP Paribas Arbitrage SNC | Position 334,800 shares | Ratio 0.47% | ▼0.12% | Below 0.5% |
| 2026-06-12 | MERRILL LYNCH INTERNATIONAL | Position 629,100 shares | Ratio 0.45% | ▼0.06% | Below 0.5% |
| 2025-11-12 | Citigroup Global Markets Limited | Position 502,400 shares | Ratio 0.45% | ▼0.06% | Below 0.5% |
| 2026-11-11 | JPM Securities Japan Co Ltd. | Position 627,200 shares | Ratio 0.44% | ▼0.13% | Below 0.5% |
| 2026-09-29 | Morgan Stanley & Co. International plc | Position 609,000 shares | Ratio 0.43% | ▼0.07% | Below 0.5% |
| 2019-11-28 | Credit Suisse Securities (Europe) Limited | Position 177,900 shares | Ratio 0.42% | ▼0.25% | Below 0.5% |
| 2019-02-19 | JANE STREET GLOBAL TRADING, LLC | Position 172,600 shares | Ratio 0.41% | ▼0.12% | Below 0.5% |
| 2019-12-09 | Credit Suisse Securities (Japan) Limited | Position 137,800 shares | Ratio 0.32% | ▼0.18% | Below 0.5% |
| 2026-01-21 | UBS AG | Position 289,000 shares | Ratio 0.22% | ▼0.33% | Below 0.5% |
| 2024-07-05 | XTX Markets Pte Ltd | Position 36,300 shares | Ratio 0.05% | ▼0.54% | Below 0.5% |
| 2024-07-08 | Macquarie Bank Limited | Position 0 shares | Ratio 0.00% | ▼1.08% | Closed |
Disclosure History 2204 in total
| Trade date | Short seller | Position (shares) | Ratio | Change | Note |
|---|---|---|---|---|---|
| 2026-11-13 | Nomura International plc | Position 2,893,300 shares | Ratio 2.05% | ▲0.07% | — |
| 2026-11-12 | Nomura International plc | Position 2,788,500 shares | Ratio 1.98% | ▲0.21% | — |
| 2026-11-11 | JPM Securities Japan Co Ltd. | Position 627,200 shares | Ratio 0.44% | ▼0.13% | Below 0.5% |
| 2026-11-11 | GOLDMAN SACHS INTERNATIONAL | Position 701,800 shares | Ratio 0.49% | ▼0.03% | Below 0.5% |
| 2026-11-09 | JPM Securities Japan Co Ltd. | Position 801,700 shares | Ratio 0.57% | ▼0.09% | — |
| 2026-11-09 | Barclays Capital Securities Ltd | Position 1,495,097 shares | Ratio 1.06% | ▼0.04% | — |
| 2026-11-06 | JPM Securities Japan Co Ltd. | Position 934,400 shares | Ratio 0.66% | ▼0.11% | — |
| 2026-11-05 | Nomura International plc | Position 2,492,100 shares | Ratio 1.77% | ▼0.21% | — |
| 2026-11-05 | JPM Securities Japan Co Ltd. | Position 1,083,700 shares | Ratio 0.77% | ▼0.10% | — |
| 2026-11-05 | GOLDMAN SACHS INTERNATIONAL | Position 738,800 shares | Ratio 0.52% | ▲0.03% | — |
| 2026-11-05 | Barclays Capital Securities Ltd | Position 1,549,697 shares | Ratio 1.10% | ▲0.14% | — |
| 2026-11-04 | GOLDMAN SACHS INTERNATIONAL | Position 701,600 shares | Ratio 0.49% | ▼0.10% | Below 0.5% |
| 2026-11-03 | Arrowstreet Capital, Limited Partnership | Position 1,398,800 shares | Ratio 0.99% | ▼0.01% | — |
| 2026-11-02 | Barclays Capital Securities Ltd | Position 1,343,797 shares | Ratio 0.96% | ▲0.07% | — |
| 2026-11-02 | Nomura International plc | Position 2,760,000 shares | Ratio 1.98% | ▼0.03% | — |
| 2026-10-29 | Nomura International plc | Position 2,799,600 shares | Ratio 2.01% | ▲0.04% | — |
| 2026-10-29 | JPM Securities Japan Co Ltd. | Position 1,216,900 shares | Ratio 0.87% | ▼0.10% | — |
| 2026-10-28 | Nomura International plc | Position 2,747,500 shares | Ratio 1.97% | ▼0.06% | — |
| 2026-10-27 | Nomura International plc | Position 2,824,000 shares | Ratio 2.03% | ▼0.13% | — |
| 2026-10-26 | Barclays Capital Securities Ltd | Position 1,244,397 shares | Ratio 0.89% | ▼0.04% | — |
| 2026-10-23 | Nomura International plc | Position 3,006,000 shares | Ratio 2.16% | ▲0.13% | — |
| 2026-10-22 | GOLDMAN SACHS INTERNATIONAL | Position 824,100 shares | Ratio 0.59% | ▼0.02% | — |
| 2026-10-20 | Nomura International plc | Position 2,917,200 shares | Ratio 2.10% | ▲0.01% | — |
| 2026-10-19 | GOLDMAN SACHS INTERNATIONAL | Position 849,900 shares | Ratio 0.61% | ▲0.09% | — |
| 2026-10-16 | Barclays Capital Securities Ltd | Position 1,303,997 shares | Ratio 0.93% | ▼0.07% | — |
| 2026-10-15 | Nomura International plc | Position 2,905,100 shares | Ratio 2.09% | ▲0.14% | — |
| 2026-10-15 | Barclays Capital Securities Ltd | Position 1,392,597 shares | Ratio 1.00% | ▲0.04% | — |
| 2026-10-14 | GOLDMAN SACHS INTERNATIONAL | Position 723,800 shares | Ratio 0.52% | ▲0.07% | — |
| 2026-10-13 | Nomura International plc | Position 2,715,500 shares | Ratio 1.95% | ▼0.09% | — |
| 2026-10-09 | Nomura International plc | Position 2,833,600 shares | Ratio 2.04% | ▼0.08% | — |
Shorted Stocks in the Same Industry Pharmaceutical
| Stock | Estimated ratio | Short sellers |
|---|---|---|
| GNI Group Ltd.2160 | 11.16% | 7 firms |
| Oncolys BioPharma Inc.4588 | 10.35% | 7 firms |
| HEALIOS K.K.4593 | 10.20% | 5 firms |
| SymBio Pharmaceuticals Limited4582 | 9.46% | 7 firms |
| Nxera Pharma Co.,Ltd.4565 | 7.35% | 5 firms |
Related Stocks Same TSE 33 sector
| Stock | Market | TSE 33 Sector | TOPIX-17 Sector | Index |
|---|---|---|---|---|
| PeptiDream Inc.4587 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Mid400 |
| Oncolys BioPharma Inc.4588 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| RIBOMIC Inc.4591 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| SanBio Company Limited4592 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| HEALIOS K.K.4593 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| MIZUHO MEDY CO.,LTD.4595 | Standard Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Kubota Pharmaceutical Holdings Co.,Ltd.4596 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Solasia Pharma K.K.4597 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Delta-Fly Pharma,Inc.4598 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| StemRIM Inc.4599 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical |